Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix

Cancer

Volumn 97, Issue 12, 2003, Pages 3114-3120

  Ohno, Tatsuya ^a   Nakayama, Yuko ^b   Nakamoto, Soken ^c   Kato, Shingo ^a   Imai, Reiko ^b   Nonaka, Tetsuo ^b   Ishikawa, Hitoshi ^b   Harashima, Koichi ^b   Suzuki, Yoshihiko ^c  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

Cervical carcinoma; Radiation therapy (RT) monitoring therapy; Serum squamous cell carcinoma (SCC) antigen

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; SERPINS; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0037714432     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11453     Document Type: Article

References (19)

1. Mitsuhashi N, Takahashi M, Nozaki M, et al. Evaluation of external beam therapy and three brachytherapy fractions for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1994;29:975-982.
2. Arai T, Nakano T, Morita S, Sakashita K, Nakamura KY, Fukuhisa K. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience. Cancer. 1992;69:175-180.
3. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 1977;40:1621-1628.
4. Sproston ARM, Roberts SA, Davidson SE, Hunter RD, West CML. Serum tumor markers in carcinoma of the uterine cervix and outcome following radiotherapy. Br J Cancer. 1995;72:1536-1540.
5. Hong JH, Tsai CS, Chang JT, et al. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:823-830.
6. Rose PG, Baker S, Fournier L, Nelson BE, Hunter RE. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence. Am J Obstet Gynecol. 1993;168:942-946.
7. Ngan HYS, Cheng GTS, Yeung WSB, Wong LC, Ma HK. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix. Gynecol Oncol. 1994;52:63-68.
8. de Bruijn HWA, Duk JM, Van der Zee AGJ, et al. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumour Biol. 1998;19:505-516.
9. Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M. Tumor associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization. Cancer. 1985;56:302-308.
10. Holloway RW, To A, Moradi M, Boots L, Watson N, Shingleton H. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay. Obstet Gynecol. 1989;74:944-949.
11. Scambia G, Panici PB, Baiocchi G, et al. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy. Am J Obstet Gynecol. 1991;164:631-636.
12. Creasman WT. New gynecologic cancer staging. Gynecol Oncol. 1995;58:157-158.
13. Scambia G, Panici PB, Foti E, et al. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. J Clin Oncol. 1994;12:2309-2316.
14. Roszak A, Bratos K, Gorny A, Mackiewicz A. Evaluation of SCC antigen in patients with advanced cervix cancer treated with radiation. Ginekol Pol. 1996;67:457-459.
15. Ngan HYS, Wong LC, Chan SYW, Ma HK. Use of squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancer. Gynecol Oncol. 1989;35:259-262.
16. Schmidt-Rhode P, Schulz KD, Sturm G, Hafner H, Prinz H, Kunzig HJ. Squamous cell carcinoma antigen for monitoring cervical cancer. Int J Biol Markers. 1988;3:87-94.
17. Ngan HYS, Chan SYW, Wong LC, Choy DTK, Ma HK. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix. Gynecol Oncol. 1990;37:260-263.
18. Esajas MD, Duk JM, de Bruijn HW, et al. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J. Clin Oncol. 2001;19:3960-3966.
19. Chou HH, Wang CC, Lai CH, et al. Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. Int J Radiat Oncol Biol Phys. 2001;51:442-448.